Trials / Conditions / Large B Cell Diffuse Lymphoma
Large B Cell Diffuse Lymphoma
6 registered clinical trials studyying Large B Cell Diffuse Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma NCT07077512 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma NCT07024147 | Peking University Cancer Hospital & Institute | Phase 1 |
| Terminated | The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated NCT03804372 | Gruppo Italiano Malattie EMatologiche dell'Adulto | Phase 2 |
| Completed | Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma NCT03450343 | Medical University of South Carolina | Phase 1 |
| Completed | FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma NCT01410630 | Jonsson Comprehensive Cancer Center | — |
| Completed | Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma NCT01448096 | Chonbuk National University Hospital | Phase 2 |